VEGFC and neoplasm: In fact, in a recent study, the overexpression of VEGF-C was found to strengthen the anti-tumor effectiveness of anti-PD-1 immunotherapy (Song et al., 2020), indicating that a bimodal form of treatment could be the most effective at treating certain subsets of tumors.